Product Pathways - Protein Translation
CA9 (D47G3) Rabbit mAb #5649
|5649S||100 µl (10 western blots)||---||In Stock||---|
|5649||carrier free and custom formulation / quantity||email request|
Already purchased this product? Write a Review.
Species cross-reactivity is determined by western blot.
Applications Key: W=Western Blotting, IP=Immunoprecipitation, IHC-P=Immunohistochemistry (Paraffin)
Specificity / Sensitivity
CA9 (D47G3) Rabbit mAb recognizes endogenous levels of total CA9 protein.
Source / Purification
Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues near the carboxy terminus of human CA9 protein.
Western blot analysis of extracts from LN18 and SW620 cells using CA9 (D47G3) Rabbit mAb.
Immunohistochemical analysis of paraffin-embedded normal human colon using CA9 (D47G3) Rabbit mAb.
Immunohistochemical analysis of paraffin-embedded cell pellets, LN18 (left) or HeLa (right), using CA9 (D47G3) Rabbit mAb.
Carbonic anhydrases (CA) are a family of ancient zinc metalloenzymes found in almost all living organisms. All CA can be divided into 3 distinct classes (α, β, and γ) that evolved independently and have no significant homology in sequence and overall folding. All functional CA catalyze the reversible hydration of CO2 into HCO3- and H+ and contain a zinc atom in the active sites essential for catalysis. There are many isoforms of CA in mammals and they all belong to the α class (1,2).
CA9 is a member of α class and is a plasma membrane protein with the catalytic domain in the extracellular space. Its expression is restricted to very few normal tissues (mainly the gastrointestinal tract) (2). CA9 expression is strongly induced by hypoxia and down-regulated by the wildtype von Hippel–Lindau (VHL) tumor suppressor protein. CA9 expression is increased in many types of tumors, especially solid hypoxic tumors with a poor responsiveness to the conventional radio- and/or chemo-therapies; CA9 is considered to be a tumor hypoxia marker and a promising target for cancer therapeutic intervention (3-5).
- Smith, K.S. et al. (1999) Proc Natl Acad Sci USA 96, 15184-9.
- Tripp, B.C. et al. (2001) J Biol Chem 276, 48615-8.
- Potter, C.P. and Harris, A.L. (2003) Br J Cancer 89, 2-7.
- Winum, J.Y. et al. (2009) Anticancer Agents Med Chem 9, 693-702.
- De Simone, G. and Supuran, C.T. (2010) Biochim Biophys Acta 1804, 404-9.
Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!
- 8112 SignalStain® Antibody Diluent
- 8114 SignalStain® Boost IHC Detection Reagent (HRP, Rabbit)
- 5425 Normal Goat Serum
- 9997 Tris Buffered Saline with Tween® 20 (TBST-10X)
- 3434 Hydroxy-HIF-1α (Pro564) (D43B5) XP® Rabbit mAb
- 5537 HIF-1β/ARNT (D28F3) XP® Rabbit mAb
- 5648 CA9 (D10C10) Rabbit mAb
- 3414 HIF-1β/ARNT (C15A11) Rabbit mAb
- 3716 HIF-1α Antibody
- 3718 HIF-1β/ARNT Antibody
- 7003 20X LumiGLO® Reagent and 20X Peroxide
- 7071 Phototope®-HRP Western Blot Detection System, Anti-rabbit IgG, HRP-linked Antibody
- 7074 Anti-rabbit IgG, HRP-linked Antibody
- 7720 Prestained Protein Marker, Broad Range (Premixed Format)
- 7727 Biotinylated Protein Ladder Detection Pack
For Research Use Only. Not For Use In Diagnostic Procedures.
Cell Signaling Technology® is a trademark of Cell Signaling Technology, Inc.